Skip to main content
. Author manuscript; available in PMC: 2008 Nov 7.
Published in final edited form as: Vaccine. 2007 Sep 4;25(45):7824–7831. doi: 10.1016/j.vaccine.2007.08.036

Figure 5. Survival analysis of challenged mice vaccinated with combinations of the SCT and Bcl-xL DNA vaccines.

Figure 5

C57BL/6 mice were intravenously challenged with 1×104 TC-1/Luciferase cells/mouse by tail-vein injection. Three days after tumor challenge, mice were treated with combinations of SCT-E6 or OVA DNA with Bcl-xL or mtBcl-xL DNA vaccines three times at 3-day intervals. Kaplan-Meier survival analysis of tumor-challenged mice treated with the various DNA vaccine combinations (*p<0.05).